Byhealth Co., Ltd (SHE:300146)
China · Delayed Price · Currency is CNY 9.10
-0.10 (-1.09%)
At close: Jul 9, 2026
Byhealth Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Byhealth stock has a consensus rating of "Buy" and an average price target of ¥12.43. The average 1-year stock price forecast is 36.59% higher than the current stock price, while the lowest is ¥10.30 (+13.19%) and the highest is ¥13.70 (+50.55%).
Price Target: ¥12.43 (+36.59%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Byhealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Feb '26 | Mar '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 3 | 3 | 3 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
6.99B
from 6.27B
Increased by 11.62%
Revenue Next Year
7.76B
from 6.99B
Increased by 10.92%
EPS This Year
0.50
from 0.41
Increased by 21.95%
EPS Next Year
0.59
from 0.50
Increased by 17.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.1B | ||
| Avg | 7.0B | ||
| Low | 6.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.3% | ||
| Avg | 11.6% | ||
| Low | 10.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.58 | ||
| Avg | 0.50 | ||
| Low | 0.42 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.5% | ||
| Avg | 22.0% | ||
| Low | 2.4% |